Biohit Oyj Past Earnings Performance
Past criteria checks 3/6
Biohit Oyj has been growing earnings at an average annual rate of 59.4%, while the Medical Equipment industry saw earnings growing at 9.6% annually. Revenues have been growing at an average rate of 9.6% per year. Biohit Oyj's return on equity is 15.3%, and it has net margins of 11.8%.
Key information
59.4%
Earnings growth rate
59.4%
EPS growth rate
| Medical Equipment Industry Growth | 28.7% |
| Revenue growth rate | 9.6% |
| Return on equity | 15.3% |
| Net Margin | 11.8% |
| Last Earnings Update | 30 Jun 2024 |
Recent past performance updates
Recent updates
Biohit Oyj's (HEL:BIOBV) Solid Profits Have Weak Fundamentals
Feb 22
Biohit Oyj Just Beat Earnings Expectations: Here's What Analysts Think Will Happen Next
Feb 17Companies Like Biohit Oyj (HEL:BIOBV) Are In A Position To Invest In Growth
Aug 04Companies Like Biohit Oyj (HEL:BIOBV) Are In A Position To Invest In Growth
Feb 09Biohit Oyj (HEL:BIOBV) Is In A Strong Position To Grow Its Business
Aug 11Biohit Oyj (HEL:BIOBV) Is In A Strong Position To Grow Its Business
Apr 13We Think Biohit Oyj (HEL:BIOBV) Can Afford To Drive Business Growth
Dec 28Revenue & Expenses Breakdown
How Biohit Oyj makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 30 Jun 24 | 14 | 2 | 4 | 0 |
| 31 Mar 24 | 14 | 2 | 4 | 0 |
| 31 Dec 23 | 13 | 2 | 4 | 0 |
| 30 Sep 23 | 12 | 1 | 4 | 0 |
| 30 Jun 23 | 11 | 1 | 4 | 0 |
| 31 Mar 23 | 11 | 1 | 4 | 0 |
| 31 Dec 22 | 11 | 1 | 4 | 0 |
| 30 Sep 22 | 11 | 1 | 4 | 0 |
| 30 Jun 22 | 11 | 1 | 4 | 0 |
| 31 Mar 22 | 10 | 0 | 4 | 0 |
| 31 Dec 21 | 9 | -1 | 3 | 0 |
| 30 Sep 21 | 9 | -2 | 3 | 0 |
| 30 Jun 21 | 8 | -2 | 3 | 0 |
| 31 Mar 21 | 8 | -3 | 3 | 0 |
| 31 Dec 20 | 7 | -3 | 3 | 0 |
| 30 Sep 20 | 8 | -3 | 3 | 0 |
| 30 Jun 20 | 8 | -3 | 3 | 0 |
| 31 Mar 20 | 9 | -2 | 3 | 0 |
| 31 Dec 19 | 10 | -1 | 3 | 0 |
| 30 Sep 19 | 10 | -2 | 3 | 0 |
| 30 Jun 19 | 10 | -2 | 3 | 0 |
| 31 Mar 19 | 10 | -2 | 3 | 0 |
| 31 Dec 18 | 10 | -2 | 3 | 0 |
| 30 Sep 18 | 10 | -2 | 3 | 0 |
| 30 Jun 18 | 10 | -2 | 3 | 0 |
| 31 Mar 18 | 9 | 2 | 3 | 0 |
| 31 Dec 17 | 9 | 6 | 3 | 0 |
| 30 Sep 17 | 9 | 6 | 4 | -1 |
| 30 Jun 17 | 8 | 6 | 4 | -1 |
| 31 Mar 17 | 8 | 1 | 4 | -1 |
| 31 Dec 16 | 8 | -3 | 5 | 0 |
| 30 Sep 16 | 7 | -4 | 5 | 1 |
| 30 Jun 16 | 6 | -4 | 5 | 2 |
| 31 Mar 16 | 7 | -3 | 5 | 2 |
| 31 Dec 15 | 6 | -3 | 5 | 2 |
| 30 Sep 15 | 6 | -3 | 5 | 2 |
| 30 Jun 15 | 6 | -4 | 5 | 2 |
| 31 Mar 15 | 5 | -4 | 5 | 2 |
| 31 Dec 14 | 4 | -4 | 5 | 2 |
| 30 Sep 14 | 4 | -5 | 5 | 2 |
| 30 Jun 14 | 4 | -5 | 6 | 2 |
| 31 Mar 14 | 4 | -6 | 7 | 1 |
| 31 Dec 13 | 3 | -6 | 7 | 1 |
Quality Earnings: BIOBV has a high level of non-cash earnings.
Growing Profit Margin: BIOBV's current net profit margins (11.8%) are higher than last year (9.7%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: BIOBV has become profitable over the past 5 years, growing earnings by 59.4% per year.
Accelerating Growth: BIOBV's earnings growth over the past year (50%) is below its 5-year average (59.4% per year).
Earnings vs Industry: BIOBV earnings growth over the past year (50%) exceeded the Medical Equipment industry 12.7%.
Return on Equity
High ROE: BIOBV's Return on Equity (15.3%) is considered low.